Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts

NCT04691622 is registered in ClinicalTrials.gov with Children's National Research Institute as lead sponsor.

NCT NCT04691622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04691622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Lead sponsor
Children's National Research Institute
Phase
Phase 1
Overall status
Recruiting
Start date
March 17, 2022
Completion date
October 30, 2028
Enrollment
48 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic stem cell transplantation (hsct), primary immunodeficiency disorders (pid), viral infection